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Enzymatic synthesis of natural (+)-aristolochene
from a non-natural substrate†
Juan A. Faraldos,a Daniel J. Grundy,a Oscar Cascon,a Stefano Leoni,a
Marc W. van der Kampb and Rudolf K. Allemann*a
The sesquiterpene cyclase aristolochene synthase from Penicillium
roquefortii (PR-AS) has evolved to catalyse with high specificity
(92%) the conversion of farnesyl diphosphate (FDP) to the bicyclic
hydrocarbon (+)-aristolochene, the natural precursor of several
fungal toxins. Here we report that PR-AS converts the unnatural
FDP isomer 7-methylene farnesyl diphosphate to (+)-aristolochene via
the intermediate 7-methylene germacrene A.Within the confined space
of the enzyme’s active site, PR-AS stabilises the reactive conformers of
germacrene A and 7-methylene germacrene A, respectively, which are
protonated by the same active site acid (most likely HOPPi) to yield the
shared natural bicyclic intermediate eudesmane cation, from which
(+)-aristolochene is then generated.
Terpenoids are found in all forms of life and comprise one of the
largest andmost structurally diverse families of natural products.1–4
Sesquiterpenoids are biosynthesized from the universal linear
C15-precursor farnesyl diphosphate (FDP, 1), which is converted
in electrophilic cyclization reactions of often exquisite specificity
to4300mostly cyclic hydrocarbon products in class I sesquiterpene
synthase catalysed processes.5 The electrophilic nature and
stereochemical precision of these cascade reactions have been
probed in vitrowith FDP isotopologues6–11 as well as with substituted
FDPs that carry fluoro,12–16 methyl17,18 and phenyl substituents.19
The ability of sesquiterpene synthases to bind such synthetic
FDP analogues as competitive inhibitors13,19,20 and occasionally
as substrates11,12,14,16–18 demonstrates their plasticity and catalytic
flexibility, properties that have been exploited for the synthesis of
several complex unnatural molecules.12,14,17,21
Aristolochene synthase from Penicillium roquefortii (PR-AS)
eﬃciently (92%) catalyses the cyclisation of 1 to the bicyclic
eremophilane hydrocarbon (+)-aristolochene (2), the precursor
of several highly oxygenated mycotoxins such us PR-toxin.8,22
This cyclisation, which generates two 6-membered rings and
introduces two double bonds and three stereo-centres with high
specificity,23–25 goes through the neutral intermediate germacrene A
(3), a flexible cyclodecadiene hydrocarbon that undergoes
reprotonation to eudesmane cation (4),24,25 most likely by proton
transfer from the by-product diphosphate (HOPPi).
26–28 Rearrange-
ment of 4 by way of a hydride and a methyl shift is followed
by a selective deprotonation at C8 to yield (+)-aristolochene (2)
(Scheme 1) together with a small amount ofB1% valencene (5),
the double bond isomer of 2 that results from deprotonation at
C6 rather than C8. PR-AS also releases B7% germacrene A (3)
prior to protonation of the central C6,C7-double bond of 3,
possibly as a consequence of a conformational change prior to
eudesmane cation formation.24,25
Scheme 1 Biosynthesis of (+)-aristolochene (2) and unnatural germacre-
noids (6–11) generated by PR-AS from the corresponding FDP analogues.
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The intermediacy of eudesmane cation (4) was inferred from
site directed mutagenesis experiments29,30 and inhibition studies
with ammonium and iminium salt analogues of 4.31,32 Evidence
for the formation of germacrene A (3) was first obtained when
PR-AS was challenged with 6,7-dihydroFDP, which was turned over
to the corresponding dihydrogermacrene A (6).21 Similarly, the
PR-AS catalysed turnover of several fluoro- and methyl-substituted
FDP analogues to the corresponding altered germacrene A analogues
(6–11)12,14,17,21 illustrated the synthetic potential of sesquiterpene
synthases for organic synthesis.11,14,16–18
If HOPPi protonates germacrene A (3) and its corresponding
base (OPPi) acts to abstract a proton from eudesmane cation (4)
in the final step of PR-AS catalysis27,28 (Scheme 1), the synthetic
space accessible to PR-AS might potentially be expandable and
7-methylene FDP (12), an unnatural FDP isomer that the enzyme
will never be exposed to in the host organism, could be eﬃciently
converted to aristolochene by reprotonation of the C7,C14 double
bond of the intermediate 7-methylene germacrene A (13) to yield
eudesmane cation (4) (Scheme 2), accomplishing for the first
time a one-step enzymatic synthesis of a structurally complex
natural sesquiterpene (2) from a non-natural, synthetic precursor.
Comparison of the relative reaction rates of the hydration for a
series of simple olefins in aqueous sulfuric acid33 suggests that
both 3 and 13 should have similar reactivity towards protonation
under general acid catalysis.
To assess the feasibility of the PR-AS catalysed cyclisation of
7-methylene-FDP (12) to 2, quantum mechanical geometry
optimisation and docking into the enzyme active were per-
formed. Previously, it was suggested that 3 exists as a mixture of
three conformers in solution with the UU conformer (enforced
by PR-AS, Fig. 1) as the predominant form (52%).34 Molecular
modeling, in which the hydrocarbon chain was confined to the
approximate active site volume, confirmed that like for 3, the
most stable conformation of 13 is the UU form. Upon relaxation
in vacuo, distances between C2 and C7 in 3 and 13 areB3.3 Å.
When the volume accessible to 3 and 13 is constrained, marked
shortening of the C2–C7 distances were observed to less than
2.5 Å (Fig. 1). Docking of the constrained structures of 3 and 13
in the (highly homologous) closed active site of aristolochene
synthase from A. terreus35 (Fig. 2) demonstrates that both fit
in the active site pocket in similar conformations and in an
orientation consistent with the expected reaction path, with e.g.
OPPi abstracting a proton from 1 or 12. As an indicator of the
direction of the second ring closure reaction (Scheme 1), we
modeled the LUMOs of 3 and 13 both in vacuo and in the
enzyme environment. Upon constrained optimisation of the
vacuum relaxed structures, the nodal configurations markedly
changed for both 3 and 13, and they remain similar when the
enzyme environment is taken into account. The calculated
LUMOs highlight the favourable orbital overlap across the ring
and demonstrate the feasibility of the acid-catalysed C2,C7 ring
closure for both 3 and 13 inside PR-AS (Fig. 1).
After expressing the PR-AS cDNA in E. coli (ESI†), GC-MS
analysis of incubations of 7-methylene FDP (12) with purified
recombinant PR-AS revealed the in vitro formation of a 5 : 3
mixture of twomajor products (Fig. 3). Comparison of the elution
profiles in the gas chromatograms and MS fragmentation patterns
from parallel incubations of 1 and 12 with PR-AS and Solidago
canadensis germacrene A synthase (GAS)36 indicated that the
Scheme 2 The PR-AS catalysed conversion of 7-methylene-FDP (12) to
(+)-aristolochene (2).
Fig. 1 Geometries and LUMOs of 3 (above) and 13 (below) in their reactive
UU conformations, after unconstrained optimisation (vacuum) (left) and
constrained optimisation and docking into the enzyme active site (right).
Under constrained volume conditions 3 and 13 become more similar and
the 2,7-contact shorter than the 2,6 contact (see also Fig. S2, ESI†).
Fig. 2 Constrained geometries of 3 (grey carbons) and 13 (purple carbons)
as docked in the active site of aristolochene synthase from A. terreus (cyan
carbons; PDB ID: 4KVY, chain A). The solvent accessible surface of the
enzyme active site is shown. For clarity, hydrogen atoms are removed from
protein residues.
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two products generated by PR-AS from 12 were aristolochene (2)
(50.1%, 15.24 minutes) and the germacrene A analogue 13
(30.1%, 16.27 minutes). In addition to 2 and 13 three minor
products were formed (Fig. 3) that made up 19.8% of the total
amount of products. Their identity was not unambiguously
determined but the possibility that they were linear 7-methylene
farnesenes was ruled out by comparison of the GC chromato-
grams and MS spectra of the products obtained from the
reaction of 12 with Mentha X piperita (E)-b-farnesene synthase
(EBFS).37 The GC retention times and comparison with the MS of
the products formed from incubations of 1 with PR-AS suggested
that the compound that eluted at 15.55 (ca. 10%) min was
valencene (5) (Fig. 3). The production of 2 from diphosphate
12 suggests that both reactions go via eudesmane cation (4)
(Schemes 1 and 2). In the case of 13, the exo double bondmay be
positioned slightly less favourably for protonation so that 13 is
longer lived in the active site than 3 and more germacrenoid 13
(30%) is released than is the case for 3 (7%). Alternatively, 13
might bind less tightly to the active site of PR-AS. Nevertheless,
the similarity of 1 and 12 and the plasticity of PR-AS lead to
similar active site conformations for both substrates so that
the initial 1,10-ring closure reactions to 3 and 13 occur along
closely related reaction paths. The molecular modeling results
demonstrate the importance of constraining the germacrene A
intermediates 3 and 13 in the active site for the protonation of
the endo-C6,C7 and exo-C7,C14 double bonds.
The investigation reported here demonstrates the remarkable
versatility of PR-AS, which eﬀectively turns over an unnatural
synthetic precursor to the natural products aristolochene (2) and
valencene (5). The PR-AS catalysed conversion of the unnatural
substrate 12 to (+)-aristolochene (2) illustrates the power of
substrate engineering for the in vitro synthesis of structurally
complex natural products utilizing sesquiterpene synthases as
biocatalysts. Our in silico work also highlights the importance of
constraining the reactants for the reactivity of intermediates
towards the generation of complex terpene products, an eﬀect
that has first been seen in the relatively easy, albeit less specific
biomimetic cyclisation reactions of squalene in the absence of
enzyme, where the hydrophobic eﬀect leads to restrictions of the
conformational space accessible to the hydrocarbon chain.38
For shorter chain isoprenoid diphosphates such as geranyl
diphosphate, farnesyl diphosphate and geranylgeranyl diphosphate
on the other hand, the enzyme is needed to act as a folding
template for eﬃcient product formation.
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